Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

322 ARTÍCULOS , VIENDO DEL 16 AL 30

Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy

Modrego PJ, Fayed N, Errea JM, Rios C, Pina MA, Sarasa M.

Eur J Neurol. 2010 Mar;17(3):405-12. doi: 10.1111/j.1468-1331.2009.02816.x. Epub 2009 Oct 28.

[High prevalence of neuroleptic drug use in elderly people with dementia]

Fort I, Formiga F, Robles MJ, Regalado P, Rodríguez D, Barranco E.

Med Clin (Barc). 2010 Feb 6;134(3):101-6. doi: 10.1016/j.medcli.2009.07.046. Epub 2009 Nov 11.

Action of estrogens in the aging brain: dementia and cognitive aging

Henderson VW.

Biochim Biophys Acta. 2010 Oct;1800(10):1077-83. doi: 10.1016/j.bbagen.2009.11.005. Epub 2009 Nov 12.

Colostral proline-rich polypeptides--immunoregulatory properties and prospects of therapeutic use in Alzheimer's disease

Janusz M, Zabłocka A.

Curr Alzheimer Res. 2010 Jun;7(4):323-33. doi: 10.2174/156720510791162377.

Towards disease-modifying treatment of Alzheimer's disease: drugs targeting beta-amyloid

Frisardi V, Solfrizzi V, Imbimbo PB, Capurso C, D'Introno A, Colacicco AM, Vendemiale G, Seripa D, Pilotto A, Capurso A, Panza F.

Curr Alzheimer Res. 2010 Feb;7(1):40-55. doi: 10.2174/156720510790274400.

Targeting p38 MAPK pathway for the treatment of Alzheimer's disease

Munoz L, Ammit AJ.

Neuropharmacology. 2010 Mar;58(3):561-8. doi: 10.1016/j.neuropharm.2009.11.010. Epub 2009 Dec 4.

Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer's disease

Cummings JL, Farlow MR, Meng X, Tekin S, Olin JT.

Clin Drug Investig. 2010;30(1):41-9. doi: 10.2165/11531270-000000000-00000.

Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models

Wisniewski T, Boutajangout A.

Brain Struct Funct. 2010 Mar;214(2-3):201-18. doi: 10.1007/s00429-009-0236-2. Epub 2009 Dec 10.

gamma-Secretase as a therapeutic target in Alzheimer's disease

Guardia-Laguarta C, Pera M, Lleó A.

Curr Drug Targets. 2010 Apr;11(4):506-17. doi: 10.2174/138945010790980349.

Neurobiological effects of Hyperforin and its potential in Alzheimer's disease therapy

Griffith TN, Varela-Nallar L, Dinamarca MC, Inestrosa NC.

Curr Med Chem. 2010;17(5):391-406. doi: 10.2174/092986710790226156.

Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia?

Cederholm T, Palmblad J.

Curr Opin Clin Nutr Metab Care. 2010 Mar;13(2):150-5. doi: 10.1097/MCO.0b013e328335c40b.

Modified immunotherapies against Alzheimer's disease: toward safer and effective amyloid clearance

Wang YJ, Zhou HD, Zhou XF.

J Alzheimers Dis. 2010;21(4):1065-75. doi: 10.3233/jad-2010-100195.

Neuroinflammation in Alzheimer's disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy?

Trepanier CH, Milgram NW.

J Alzheimers Dis. 2010;21(4):1089-99. doi: 10.3233/jad-2010-090667.

Dementia

Warner JP, Butler R, Gupta S.

BMJ Clin Evid. 2010 Apr 8;2010:1001.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias